semaglutide or tirzepatide weight loss vs Tirzepatide: Which Is Better for Loss? Tirzepatide GLP-1 medication may be

Efficacy and safety of adding the dipeptidyl peptidas-4 inhibitor alogliptin to metformin therapy in patients with type 2 diabetes inadequately controlled with metformin monotherapy: a multicentre, randomised, double-blind, placebo-controlled study

Metformin: Evidence suggests that GLP-1 receptor agonists may offer superior benefits compared to metformin in terms of weight loss and insulin resistance improvement in overweight or obese women with PCOS

From there, your provider will likely increase the dose in 2.5 mg increments every four weeks as needed, climbing through 5 mg , 7.5 mg , 10 mg , 12.5 mg , and up to a maximum of 15 mg per week

Leonard GD, Fojo T, Bates SE